Their contribution as principal drugs may be that CR and MOR interact, cooperate, or inhibit with other drugs at a specific dose in classical LPD, so as to achieve a better therapeutic effect on CG. This evidence concerns the gene OPRM1 and disseminated peritoneal leiomyomatosis.